Aggrastat Injection, Solution
Product Images NDC 25208-002

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Aggrastat (NDC 25208-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medicure International Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-5mg (100ml Label)

Label for Aggrastat (tirofiban hydrochloride) Injection, 5 mg per 100 mL (50 mcg per mL) intravenous solution. It is a single-dose vial manufactured for Medicure International Inc. and distributed by Medicure Pharma Inc. The label includes storage instructions, caution to protect from light, and NDC 25208-002-03.*

FDA Label Image

15ml-label (15ml Label)

Label for Aggrastat (tirofiban hydrochloride) Injection, 3.75 mg per 15 mL (250 mcg per mL) intravenous solution. The label states it is a single-dose vial for intravenous use only with instructions to discard unused portion and see the insert for usual adult dosage. Manufactured by Medicure International Inc and Emergent BioSolutions, Baltimore, MD, and distributed by Medicure Pharma, Inc., Princeton, NJ. The vial size is 15 mL. The label also cautions to protect from light during storage.*

FDA Label Image

Small-carton (3 75 mg Carton)

Label for AGGRASTAT (tirofiban hydrochloride) Injection, solution 3.75 mg per 15 mL (250 mcg/mL) for intravenous use. The 15 mL single-dose vial is protected from light and manufactured for Medicure International Inc by Emergent BioSolutions. Distributed by Medicure Pharma, Princeton, NJ, USA. Contains storage instructions and active/inactive ingredients information.*

FDA Label Image

Carton-100ml (50 Mcg Carton)

AGGRASTAT 5 mg per 100 mL (50 mcg per mL) injection, premixed intravenous solution in a 100 mL single-dose vial. The label shows brand and generic names (tirofiban hydrochloride), storage instructions, and manufacturer information for Medicure International Inc. The red and white label includes barcodes and dosage information.*

FDA Label Image

Figure1 (Aggrastat Figure1)

A line graph titled 'Composite Endpoint 180-Day Follow-Up' comparing the proportion with endpoint over study days between Heparin and AGGRASTAT plus Heparin groups. The graph shows risk reduction percentages of 22% and 19% at different points, with corresponding p-values of 0.029 and 0.024, respectively.*

FDA Label Image

Structure (Aggrastat Struct Formula)

Chemical structure of tirofiban hydrochloride monohydrate, the active ingredient in AGGRASTAT injection, solution. The diagram shows the molecular formula including a piperidine ring and a sulfonamide functional group along with hydrochloride and water molecules.*

FDA Label Image

Equation-1 (Equation 1)

A formula illustrating the calculation for bolus volume in milliliters, based on body weight in kilograms, drug dosage in micrograms per kilogram, and the drug concentration of 250 micrograms per milliliter.*

FDA Label Image

Equation-2 (Equation 2)

A mathematical formula calculating the bolus volume in milliliters based on body weight in kilograms for a medication dosage, showing the expression as 25 mcg/kg multiplied by body weight divided by 50 mcg/mL. The formula is related to intravenous administration dosage calculations.*

FDA Label Image

Equation-3 (Equation 3)

A dosing calculation formula showing the infusion rate for patients with creatinine clearance over 60 mL/min. The formula calculates infusion rate in mL/h based on weight, dosage, and drug concentration parameters.*

FDA Label Image

Equation-4 (Equation 4)

A calculation formula demonstrating the infusion rate for patients with creatinine clearance (CrCl) greater than 60 mL/min. The equation calculates infusion rate in mL/hour based on dosage per body weight and drug concentration, relevant to intravenous administration of the medication.*

FDA Label Image

Equation-5 (Equation 5)

A mathematical formula for calculating the infusion rate of a medication for patients with creatinine clearance less than or equal to 60 mL/min. The formula includes dosage in mcg per kg per minute, body weight in kg, and time conversion factors, divided by drug concentration in mcg/mL.*

FDA Label Image

Pack 1 100ml

AGGRASTAT (tirofiban hydrochloride) Injection 5 mg per 100 mL premixed intravenous solution. Single-dose 100 mL container, sterile and nonpyrogenic. The label shows storage instructions, usage cautions, and manufacturer information for Medicure International Inc. Includes barcodes and NDC 25208-02-01.*

FDA Label Image

Insert (250 mL)

AGGRASTAT (Tirofiban Hydrochloride) Injection single-dose container, 250 mL intravenous solution. Label states 12.5 mg per 250 mL (50 mcg/mL) concentration, sterile and nonpyrogenic. Manufactured by Laboratorios Grifols S.A. for Medicure International Inc, distributed by Medicure Pharma. Includes storage and usage instructions.*

FDA Label Image

Pack 2 100ml

Label for AGGRASTAT (tirofiban hydrochloride) Injection, solution for intravenous use, with a strength of 5 mg per 100 mL (50 mcg per mL). The single-dose container holds 100 mL. Label indicates isosmotic and sterile nonpyrogenic properties. Manufactured and distributed by Medicure International, Inc., with additional information on cautions, storage, and composition.*

FDA Label Image

Container (Pack 2 250ml)

AGGRASTAT (tirofiban hydrochloride) Injection 12.5 mg per 250 mL (50 mcg per mL) premixed intravenous solution in a single-dose container. The label indicates it is iso-osmotic, sterile, and nonpyrogenic. Manufactured for Medicure International Inc by Laboratorios Grifols S.A. in Spain, distributed by Medicure Pharma Inc, USA.*

FDA Label Image

Pack 3 100ml

AGGRASTAT (Tirofiban Hydrochloride) injection label for a 100 mL single-dose container. The label states it is a premixed, iso-osmotic, sterile, nonpyrogenic intravenous solution for prescription use only. It provides details on contents, storage, and cautions and shows barcodes and distributor information for Medicure Pharma, Inc.*

FDA Label Image

Carton (Pack 3 250ml)

AGGRASTAT (tirofiban hydrochloride) Injection label for the 12.5 mg per 250 mL (50 mcg per mL) intravenous solution. The label states single-dose container, iso-osmotic, sterile nonpyrogenic, and includes manufacturer and distributor information for Medicure International, Inc. The package size is 250 mL with storage and caution details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.